Grade: F — Major Red Flags
Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles
Data: SEC EDGAR 10-K (Filed 2026-02-24) + Yahoo Finance
Auditor: Ernst & Young LLP (per IBM Annual Report)
One-line verdict: IBM's FY2025 represents the strongest year in Arvind Krishna's tenure — revenue grew 7.6% to $67.5B, net income surged 76% to $10.6B, and free cash flow of $11.5B reached a multi-year high. The Software segment is the growth engine, powered by Red Hat, watsonx AI platform, and the $6.4B HashiCorp acquisition. But IBM's balance sheet remains a monument to decades of financial engineering: $64.6B of total debt against $14.4B of cash (22% coverage), and goodwill plus intangibles of $79.1B representing 242% of stockholders' equity. The M-Score of -2.40 is clean, and cash flow quality is strong at 1.25x net income. IBM is not manipulating earnings — it is simply carrying a balance sheet that reflects decades of acquisitions funded by debt, in a business that generates enough cash flow to service that debt but never enough to pay it down.
| Metric | Result |
|---|---|
| Red Flags | **2** |
| Watch Items | **1** |
| Checks Completed | **17/18** |
| Beneish M-Score | **-2.40** (clean) |
| F-Score (Fraud Probability) | **1.57** (0.58% probability) |
| Altman Z-Score | **4.10** (safe zone) |
| Auditor | Ernst & Young LLP — Unqualified opinion |
| Fiscal Year | 2025 (ended December 31, 2025) |
| Report Date | 2026-04-05 |
Revenue: Software Leading, Consulting Lagging
Per the financial data and segment disclosures in the 10-K (IBM incorporates financial details by reference to its Annual Report to Stockholders):
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Revenue | $67,536M | $62,753M | $61,860M |
| Gross Profit | $39,297M | $35,551M | $34,300M |
| Gross Margin | 58.2% | 56.7% | 55.4% |
| Net Income | $10,593M | $6,023M | $7,502M |
| Net Margin | 15.7% | 9.6% | 12.1% |
Revenue grew 7.6% overall. IBM operates through four segments: Software, Consulting, Infrastructure, and Financing. The 10-K states that segment information and revenue by product classes can be found on pages 65 to 68 of the Annual Report.
The competitive landscape per the filing: Software competes with "Alphabet (Google), Amazon, BMC, Broadcom, Microsoft, Oracle, Salesforce, SAP and Splunk." Consulting faces "Accenture, Capgemini, India-based service providers." Infrastructure competes with "Dell Technologies, Hewlett-Packard Enterprise (HPE), Intel, NetApp and Pure Storage."
Gross margin expanded 1.5 percentage points to 58.2% — the fourth consecutive year of improvement. This reflects the strategic pivot toward higher-margin software and away from lower-margin hardware and services.
The HashiCorp Acquisition
The 10-K XBRL data reveals significant 2025 acquisition activity. IBM completed the acquisition of HashiCorp during FY2025. The XBRL tags show acquisitions allocated across both the Software and Consulting segments (ibm:A2025AcquisitionsMember, ibm:HashiCorpMember). Customer relationships and developed technology intangibles were acquired with useful lives spanning several years.
This follows IBM's well-established pattern of acquiring infrastructure software companies (Red Hat in 2019, Turbonomic in 2021, Apptio in 2023) and folding them into the Software segment.
Cash Flow: Strong and Consistent
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income | $10,593M | $6,023M | $7,502M | $1,640M |
| Operating Cash Flow | $13,193M | $13,445M | $13,931M | $10,435M |
| Free Cash Flow | $11,455M | $11,760M | $12,121M | $8,463M |
| CFFO/NI | 1.25x | 2.23x | 1.86x | 6.36x |
Free cash flow has been remarkably stable: $11.5B, $11.8B, $12.1B over the last three years. The CFFO/NI ratio of 1.25x in FY2025 is healthy — each dollar of profit is backed by $1.25 of cash. The prior years' higher ratios reflected lower reported net income rather than stronger cash generation.
IBM's FCF consistency is its strongest attribute from a forensic accounting perspective. Operating cash flow has exceeded $10B for four consecutive years regardless of the noise in reported earnings.
Balance Sheet: The Debt Mountain
| Item | FY2025 | FY2024 |
|---|---|---|
| Cash + Short-term Investments | $14,417M | $14,591M |
| Total Debt | $64,607M | $58,396M |
| Goodwill + Intangibles | $79,100M* | ~$71,200M* |
| Stockholders' Equity | $32,649M* | $27,308M* |
*Estimated from trends data and financial proportions.
Total debt increased $6.2B to $64.6B — driven by acquisition financing for HashiCorp and other M&A. Cash remained flat at $14.4B. The debt-to-equity ratio is approximately 2.0x.
IBM's debt structure is predominantly long-term fixed-rate notes with maturities staggered across decades — the 10-K lists bonds maturing from 2026 through 2040+, with interest rates ranging from 0.300% to 5.600%. This is a well-managed, investment-grade debt portfolio that benefits from IBM's A-rated credit.
The 10-K warns: "The company acquires other companies, including the intangible assets of those companies. The company may not realize all the economic benefit from those acquisitions, which could cause an impairment of goodwill or intangible assets."
The 18-Point Screening
| # | Check | Result | Detail |
|---|---|---|---|
| A1 | DSO Change | PASS | DSO 44 days, +4 days YoY. Modest increase |
| A2 | AR vs Revenue Growth | WATCH | AR +19.2% exceeds revenue +7.6%. Gap widening |
| A3 | Revenue vs CFFO | PASS | Revenue +7.6%, CFFO -1.9%. Cash roughly tracks |
| B1 | Inventory vs COGS | PASS | Inventory -5.4% vs COGS +3.8%. Deleveraging |
| B2 | CapEx vs Revenue | PASS | CapEx +3.1% vs revenue +7.6%. Normal |
| B3 | SG&A Ratio | PASS | SG&A/Gross Profit = 46.2%. Normal |
| B4 | Gross Margin | PASS | 58.2%, +1.5pp. Expanding |
| C1 | CFFO vs Net Income | PASS | CFFO/NI = 1.25. Healthy |
| C2 | Free Cash Flow | PASS | FCF $11.5B, FCF/NI = 1.08 |
| C3 | Accruals Ratio | PASS | -1.7%. Low accruals |
| C4 | Cash vs Debt | **FAIL** | Cash $14.4B covers only 22% of debt $64.6B |
| D1 | Goodwill + Intangibles | **FAIL** | $79.1B = 242% of equity. Massive acquisition legacy |
| D2 | Leverage | PASS | Debt/EBITDA = 3.7x. Manageable |
| D3 | Soft Asset Growth | PASS | Other assets +18.2% vs revenue +7.6%. Normal |
| D4 | Asset Impairment | N/A | No write-off data |
| E1 | Serial Acquirer FCF | PASS | FCF after acquisitions positive |
| E2 | Goodwill Surge | PASS | Goodwill +11% YoY. HashiCorp addition |
| F1 | Beneish M-Score | PASS | M-Score = -2.40 (< -2.22). Clean |
Key Risks from the 10-K
1. Serial Acquisition Dependency
IBM's growth strategy depends on continuous acquisitions — Red Hat (2019), Apptio (2023), HashiCorp (2025), and numerous smaller deals. Each acquisition adds goodwill and intangible assets to a balance sheet already carrying $79B of such assets. The filing explicitly warns of "the company failing to achieve anticipated revenue improvements and cost savings" from acquisitions and "the assumption of liabilities related to litigation."
2. AI Competitive Intensity
The 10-K dedicates substantial risk factor language to AI: "If IBM is unable to continue its cutting-edge innovation in a highly competitive and rapidly evolving environment or is unable to commercialize such innovations... the company could fail in its ongoing efforts to maintain and increase its market share." IBM competes against Alphabet, Amazon, Microsoft, and specialized AI providers — companies with significantly larger R&D budgets.
3. Consulting Cyclicality
Consulting is IBM's most cyclically sensitive segment, competing with Accenture and Indian IT services providers. The filing notes that "general economic conditions, including sudden shifts in regional or global economic activity may impact the company's financial results."
4. AR Growth Warrants Monitoring
Accounts receivable grew 19.2% against 7.6% revenue growth. While the filing does not explain this gap in the 10-K narrative (much of IBM's financial detail is incorporated by reference to the Annual Report), the consistent pattern of AR outpacing revenue across many large technology companies merits attention.
5. Goodwill Impairment Risk
$79B in goodwill and intangibles has never been materially impaired. The filing warns: "If our goodwill or net intangible assets become impaired, we may be required to record a charge to the Consolidated Income Statement." Given the scale, even a 5% impairment would represent a $4B charge.
Key Financial Trends (4-Year)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $60,530M | $61,860M | $62,753M | $67,536M |
| Net Income | $1,640M | $7,502M | $6,023M | $10,593M |
| Gross Margin | 54.0% | 55.4% | 56.7% | 58.2% |
| Net Margin | 2.7% | 12.1% | 9.6% | 15.7% |
| CFFO | $10,435M | $13,931M | $13,445M | $13,193M |
| FCF | $8,463M | $12,121M | $11,760M | $11,455M |
| Cash | $8,738M | $13,441M | $14,591M | $14,417M |
| Total Debt | $54,013M | $59,935M | $58,396M | $64,607M |
Summary
Grade: F. Two red flags and one watch item. Strong operations weighed down by decades of acquisition-funded debt.
IBM's FY2025 operations are the best in years: $67.5B revenue (+7.6%), $10.6B net income (+76%), 58.2% gross margins (four-year improvement trend), and $11.5B in free cash flow. The M-Score of -2.40 is clean. Cash flow quality is strong. The Software segment is growing, and the HashiCorp acquisition strengthens IBM's infrastructure automation capabilities.
The two red flags are entirely balance-sheet-driven:
IBM's Altman Z-Score of 4.10 places it in the safe zone despite the leverage — reflecting the company's strong revenue base and consistent cash generation. But the screening framework treats 22% cash-to-debt coverage as a critical vulnerability regardless of Z-Score, and the $79B intangible load amplifies the risk.
**Disclaimer**: This report is based on International Business Machines Corporation's fiscal year 2025 10-K filed with the SEC on February 24, 2026. This is NOT investment advice.
**About EarningsGrade**: We screen earnings reports for financial red flags using an 18-point forensic framework. Grade F means major red flags were detected that require thorough investigation.